Dysregulation of TGFβ expression is an essential driver of multiple diseases, such as fibrosis, cancer, immune disease, and vasculopathies [30,32,33,34,35], where it exerts differential functions in a context- and tissue-dependent manner. This evidence concerns the gene TGFB1 and cancer.